Peter Greenleaf Insider Trading $SVRA Savara Inc
Get free email notifications about insider trading for Peter Greenleaf.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Greenleaf. Peter Greenleaf is Senior VP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales and Marketing in MEDIMMUNE INC /DE ($MEDI) and Director in ANTARES PHARMA, INC. ($ATRS) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and Director in Mast Therapeutics, Inc. ($MSTX) and CEO in Sucampo Pharmaceuticals, Inc. ($SCMP) and Chief Executive Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and Director in Mirna Therapeutics, Inc. ($MIRN) and in Cerecor Inc. ($CERC) and Chief Executive Officer in Cerecor Inc. ($CERC) and Director in Cerecor Inc. ($CERC) and Chief Executive Officer in Aurinia Pharmaceuticals Inc. ($AUPH).
Peter Greenleaf in Savara Inc
Trading Symbol: SVRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 23 2017
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Greenleaf in Savara Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, AUPH, BDSI, CERC, EYEG, MEDI, SVRA, SCMP, SYBX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 23 2017 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.00 | 45,535 | 0 | 45,535 | |
Jun 17 2016 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.43 | 79,551 | 34,207 | 79,551 | |
Nov 09 2015 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.45 | 37,794 | 17,007 | 37,794 | |
Nov 09 2015 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.45 | 64,791 | 29,156 | 64,791 |
Page: 1